SMMT
Summit Therapeutics Inc · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website ummittxinc.com
- Employees(FY) 76
- ISIN US86627T1088
Performance
+1.39%
1W
+136.98%
1M
+137.69%
3M
+237.97%
6M
+206.9%
YTD
+224.29%
1Y
Profile
Summit Therapeutics Inc., a biopharmaceutical company, research and develops primarily oncology therapies in the United States, and the United Kingdom. The company's product pipeline includes SMT-738, a novel class of precision antibiotics for treatment which is in preclinical stage for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. It has a collaboration and license agreement with Akeso, Inc. for research and develop Ivonescimab (AK112) and SMT112, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis. The company was founded in 2003 and is headquartered in Cambridge, Massachusetts.
Investment Analysis Report: SMMT
Overview
In this investment analysis report, we will delve into the financial statements of SMMT, a company operating in the Health Technology sector within the Biotechnology industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating cash flow...
Technical Analysis of SMMT 2024-05-31
Overview:
In analyzing the technical indicators for SMMT over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the next few days.
Trend Indi...
Recent News & Updates
- 2024-01-08 09:00
- 2024-01-07 20:00
- 2024-01-03 07:30
- 2024-01-02 18:30
- 2023-11-27 06:38
- 2023-11-08 12:27
- 2023-11-07 09:07
- 2023-11-07 07:00
- 2023-11-06 18:00
- 2023-11-02 16:41
- 2023-11-02 04:41
- 2023-11-01 20:00
- 2023-10-31 08:00
- 2023-10-30 20:00
- 2023-10-26 08:00
- 2023-10-25 20:00
- 2023-10-19 08:00
- 2023-10-18 20:00
- 2023-10-16 11:01
- 2023-10-15 19:00
- 2023-09-29 00:43
25 Biggest Stocks with Negative Beta(Yahoo Finance)
- 2023-08-09 10:19
Q2 2023 Summit Therapeutics Inc Earnings Call(Yahoo Finance)
- 2023-08-08 19:00
- 2023-08-01 20:00
- 2023-07-10 23:48
- 2023-06-03 20:00
- 2023-05-31 19:30
Ivonescimab Updated Data to be Featured at ASCO 2023(Yahoo Finance)
- 2023-05-21 21:30
11 Stocks with Heavy Insider Buying in 2023(Yahoo Finance)
- 2023-05-17 21:46
- 2023-05-16 01:21
Why Shares of Summit Therapeutics Slumped on Tuesday(Yahoo Finance)